Results 251 to 260 of about 77,038 (354)

Spatiotemporal Immune Dynamics in Experimental Retinal Ganglion Cell Injury Models

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 10, October 2025.
ABSTRACT Background The damage and regeneration of retinal ganglion cells (RGCs) have been extensively studied. Among them, immune cells in different parts of the visual pathway play an important role in injury, regeneration and repair, but a comprehensive analysis of their spatial and temporal distribution is lacking.
Chongqing Yang   +6 more
wiley   +1 more source

Decellularised Cartilage‐Based Hydrogels Functionalised With Chondroitin Sulphate and Quercetin: The Impact on Chondrogenesis

open access: yesJournal of Biomedical Materials Research Part A, Volume 113, Issue 10, October 2025.
Decellularized cartilage particles were solubilized to form a pre‐gel solution, functionalized with aldehyde‐modified chondroitin sulphate and quercetin. The functionalized pre‐gel underwent thermogelation at 37°C to form a hydrogel. Created in BioRender. Granja, P. (2025) https://BioRender.com/0alijn6.
Nuno Da Silva Rosa   +5 more
wiley   +1 more source

Dynamic Loading Does Not Interfere With the Initial Repopulation of Decellularized Tendons: An Ex Vivo Study

open access: yesJournal of Biomedical Materials Research Part A, Volume 113, Issue 10, October 2025.
ABSTRACT Rupture of the anterior cruciate ligament (ACL) is a common injury resulting in joint instability. Tendon autografts, the gold standard to reconstruct a ruptured ACL, contain dead or dying cells upon implantation that can initiate early localized catabolic and inflammatory events.
Janne Spierings   +6 more
wiley   +1 more source

CANT1 Is Involved in Collagen Fibrogenesis in Tendons by Regulating the Synthesis of Dermatan/Chondroitin Sulfate Attached to the Decorin Core Protein. [PDF]

open access: yesInt J Mol Sci
Yamashita R   +8 more
europepmc   +1 more source

Exploring the 3D Bioprinting Landscape in the Delivery of Active Pharmaceutical Compounds for Therapeutic and Regenerative Medicine Applications

open access: yesJournal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 113, Issue 10, October 2025.
Three‐dimensional (3D) bioprinting is revolutionizing drug delivery and regenerative medicine by enabling personalized, controlled‐release therapeutic systems. This review explores advancements in biocompatible bioinks, nanomedicines, and 3D‐printed drug delivery constructs, including scaffolds, implants, and bioactive hydrogels.
Khonzisizwe Somandi, Yahya E. Choonara
wiley   +1 more source

Home - About - Disclaimer - Privacy